Will a hantavirus antiviral treatment be approved by December 31, 2026?
Ribavirin has shown limited efficacy against hantavirus. No specific antiviral is approved. Paxlovid took 20 months from COVID emergence to FDA EUA — a similar timeline here would be tight.
Resolves YES if any regulatory agency grants approval or emergency authorization for an antiviral specifically indicated for hantavirus treatment before 2026-12-31.
On settlement the oracle attaches a signed snapshot of each source URL plus a SHA-256 hash of the page content captured at resolution time. Disputes have a 7-day arbitration window.
cited: FDA / EMA regulatory decisions + ClinicalTrials.gov
Resolution sources · 2
v2 API returns JSON. Resolves the vaccine-Phase-2 market. Filter `statusModule.overallStatus` and `phase`.
Wire-grade source; resolves the NYT/major-media markets.
ETL workers poll these feeds and merge into the resolution oracle.full registry